Showing posts with label basal cell carcinoma. Show all posts
Showing posts with label basal cell carcinoma. Show all posts
Thursday, March 5, 2015
Saturday, April 21, 2012
Basal Cell Carcinoma
Author: Dr Jack Resneck Jr University of California San Francisco 2008-07-28
Introduction:
Basal Cell Carcinoma (BCC) is the most common cancer in humans worldwide, with more than 800,000 new cases annually in the US alone, where its incidence has been rising at about 10% per year. It is most common in fair-skinned individuals with a significant lifetime history of intense, intermittent sun exposure. Most BCCs begin as a pink or translucent bump on the skin. There are numerous treatments available for BCCs, and the overwhelming majority of patients are cured. If left untreated, BCC can be disfiguring and destroy tissue locally, but metastasis is extremely uncommon. Among those rare patients who develop metastatic disease, fewer than 10% survive more than 5 years. Most deaths from BCC are due to direct extension of the malignancy into a vital structure in patients who remain untreated for several years (rather than metastatic disease).
Introduction:
Basal Cell Carcinoma (BCC) is the most common cancer in humans worldwide, with more than 800,000 new cases annually in the US alone, where its incidence has been rising at about 10% per year. It is most common in fair-skinned individuals with a significant lifetime history of intense, intermittent sun exposure. Most BCCs begin as a pink or translucent bump on the skin. There are numerous treatments available for BCCs, and the overwhelming majority of patients are cured. If left untreated, BCC can be disfiguring and destroy tissue locally, but metastasis is extremely uncommon. Among those rare patients who develop metastatic disease, fewer than 10% survive more than 5 years. Most deaths from BCC are due to direct extension of the malignancy into a vital structure in patients who remain untreated for several years (rather than metastatic disease). 
Subscribe to:
Comments (Atom)